David Erlinge
451 – 460 of 473
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 1998
-
Mark
Inhibition of angiotensin II-induced contraction by losartan in human coronary arteries
(
- Contribution to journal › Article
-
Mark
P2U-receptor mediated endothelium-dependent but nitric oxide-independent vascular relaxation
(
- Contribution to journal › Article
-
Mark
Phenotype changes of the vascular smooth muscle cell regulate P2 receptor expression as measured by quantitative RT-PCR
(
- Contribution to journal › Article
-
Mark
Extracellular ATP: a growth factor for vascular smooth muscle cells
(
- Contribution to journal › Scientific review
- 1997
-
Mark
In vivo receptor characterization of neuropeptide Y-induced effects in consecutive vascular sections of cat skeletal muscle
(
- Contribution to journal › Article
- 1996
-
Mark
Neuropeptide Y potentiates noradrenaline-induced contraction through the neuropeptide Y Y1 receptor
(
- Contribution to journal › Article
-
Mark
Tyrphostin inhibition of ATP-stimulated DNA synthesis, cell proliferation and fos-protein expression in vascular smooth muscle cells
(
- Contribution to journal › Article
-
Mark
Contractile effects of neuropeptide Y in human subcutaneous resistance arteries are mediated by Y1 receptors
(
- Contribution to journal › Article
-
Mark
Effects of phosphorothioated neuropeptide Y Y1-receptor antisense oligodeoxynucleotide in conscious rats and in human vessels
(
- Contribution to journal › Article
-
Mark
alpha-Trinositol: a functional (non-receptor) neuropeptide Y antagonist in vasculature
(
- Contribution to journal › Article